Skip to main content
Equibles

FMR LLC

Position in PRLD — Prelude Therapeutics Inc

CIK 315066 BOSTON, MA
Back to PRLD Full portfolio

Position in PRLD

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$30,002
+$9,452 QoQ
Shares Held
5,629
-6.3% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#59
of 75 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 82% Shared 0% None 18%

Common Shares in PRLD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FMR LLC holds $61,908,415,112 across 370 Biotechnology names. PRLD ranks #290 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 5,231,452 $4,853,584,218
2 ALNY
Alnylam Pharmaceuticals, Inc.
 15,023,962 $4,522,663,276
3 MRNA
Moderna, Inc.
 51,859,891 $3,631,748,165
4 ROIV
Roivant Sciences Ltd.
 81,020,390 $2,867,311,601
5 RVMD
Revolution Medicines, Inc.
 12,200,422 $2,284,895,029
6 IONS
Ionis Pharmaceuticals Inc
 24,631,956 $1,953,067,789
7 INSM
INSMED Inc
 16,143,583 $1,721,228,815
8 KRYS
Krystal Biotech, Inc.
 4,418,197 $1,642,111,277

All Filings in PRLD

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $30,002 5,629
2026-03-31 $20,550 6,009
2025-12-31 $17,840 6,152
2025-09-30 $13,102 9,099
2025-06-30 $9,034 11,167
2025-03-31 $15,542 20,238
2024-12-31 $10,840 8,502
2024-09-30 $15,769 7,618
2024-06-30 $36,480 9,575
2024-03-31 $54,747 11,550
2023-12-31 $1,130,212 264,687
2023-09-30 $15,856,127 5,131,433
2023-06-30 $26,730,989 5,940,220
2023-03-31 $25,916,064 4,546,678
2022-12-31 $27,721,134 4,589,592
2022-09-30 $30,660,794 4,638,547
2022-06-30 $22,461,496 4,302,969
2022-03-31 $37,066,157 5,371,907
2021-12-31 $73,939,714 5,938,933
2021-09-30 $220,489,560 7,055,666
2021-06-30 $187,598,045 6,552,499
2021-03-31 $270,903,794 6,252,107
2020-12-31 $301,222,852 4,209,963
2020-09-30 $94,258,209 3,128,384